The Children's Hospital Of Zhejiang University School Of Medicine
Clinical trials sponsored by The Children's Hospital Of Zhejiang University School Of Medicine, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- 500 children, one goal: mapping the best care for a rare leukemia Results expected Sep 2026 (estimated)
- New ultrasound technique could sharpen diagnosis for Kids' belly issues Results expected Sep 2026 (estimated)
- Engineered immune cells aim to tame childhood arthritis and lupus Results expected Dec 2026 (estimated)
- Lupus study watches immune system in kids on experimental treatment Results expected Dec 2026 (estimated)
- First gene therapy trial launches for rare childhood disease MLIV Results expected Jan 2027 (estimated)
-
Engineered immune cells take on rare autoimmune disease in kids
Disease control PausedThis early-stage trial tests whether a type of immunotherapy called CAR-T cells can safely treat children with severe systemic sclerosis, a rare autoimmune disease that causes skin thickening and organ damage. The treatment involves collecting the child's own immune cells, engine…
Phase 1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
CAR-T therapy aimed at tough kidney disease in kids — but trial never started
Disease control CancelledThis was a planned early-stage trial to test whether anti-CD19 CAR-T cells could safely help children with multi-drug resistant nephrotic syndrome, a serious kidney condition. The study was withdrawn before any patients were enrolled, so no data on safety or effectiveness were co…
Phase 1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Promising CAR-T trial for kids with rare vasculitis pulled before start
Disease control CancelledThis trial aimed to test whether anti-CD19 CAR-T cells could safely and effectively treat children with refractory ANCA-associated vasculitis, a rare autoimmune disease. The study was withdrawn before enrolling any participants, so no results are available. It was designed for ch…
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise for rare childhood leukemia
Disease control OngoingThis study tests whether adding a drug called selinexor to standard chemotherapy can help children with a specific, high-risk form of acute myeloid leukemia (NUP98-positive AML). Ten children will receive the combination during their first two rounds of treatment. The goal is to …
Phase 2 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
First gene therapy trial launches for rare childhood disease MLIV
Disease control By invitation onlyThis early-stage trial tests a gene therapy called AAV9.hMCOLN1co in one child with Mucolipidosis Type IV (MLIV), a rare genetic disorder. The therapy is given as a single injection into the spinal fluid. The main goal is to check safety, but researchers will also look for any si…
Phase 1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Engineered immune cells take on lupus in early trial
Disease control OngoingThis early-stage study tests a new treatment for people with refractory systemic lupus erythematosus, a severe form of lupus that doesn't improve with standard medicines. The treatment uses the patient's own immune cells, modified to target and attack faulty immune cells that dri…
Phase 1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
AI ultrasound could revolutionize childhood cancer diagnosis
Diagnosis OngoingThis study aims to create an intelligent ultrasound system that can better diagnose and classify neuroblastoma tumors in children. Researchers will use ultrasound images and medical data from 300 children to train a computer model to identify tumor types, predict risk, and guide …
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC